LIGHT CHAIN AMYLOIDOSIS

Clinical trials for LIGHT CHAIN AMYLOIDOSIS explained in plain language.

Never miss a new study

Get alerted when new LIGHT CHAIN AMYLOIDOSIS trials appear

Sign up with your email to follow new studies for LIGHT CHAIN AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Dual-Attack cell therapy trial offers hope for Tough-to-Treat amyloidosis

Disease control Recruiting now

This study is testing a new type of personalized cell therapy called AZD0120 in people with AL amyloidosis that has come back or hasn't responded to prior treatments. The therapy involves modifying a patient's own immune cells to target and destroy the harmful cells causing the d…

Matched conditions: LIGHT CHAIN AMYLOIDOSIS

Phase: PHASE1, PHASE2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control

Last updated Mar 04, 2026 15:30 UTC

LIGHT CHAIN AMYLOIDOSIS

Get alerted when new LIGHT CHAIN AMYLOIDOSIS trials appear

Dual-Attack cell therapy trial offers hope for Tough-to-Treat amyloidosis